314
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Genomic Variation in the MAP3K5 Gene is Associated with β-Thalassemia Disease Severity and Hydroxyurea Treatment Efficacy

, , , , , , , , , , , , , , , , , & show all
Pages 469-483 | Published online: 05 Apr 2013

References

  • Patrinos GP , GrosveldFG. Pharmacogenomics and therapeutics of hemoglobinopathies. Hemoglobin32(1–2) , 229–236 (2008).
  • Rochette J , CraigJE, TheinSL. Fetal hemoglobin levels in adults. Blood Rev.8(4) , 213–224 (1994).
  • Boyer SH , DoverGJ, SerjeantGR et al. Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene cluster. Blood 64(5) , 1053–1058 (1984).
  • Garner C , TatuT, ReittieJE et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95(1) , 342–346 (2000).
  • Gianni AM , BregniM, CappelliniMD et al. A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster. EMBO J. 2(6) , 921–925 (1983).
  • Gilman JG , HuismanTH. DNA sequence variation associated with elevated fetal G gamma globin production. Blood66(4) , 783–787 (1985).
  • Gilman JG , JohnsonME, MishimaN. Four base-pair DNA deletion in human A gamma globin-gene promoter associated with low A gamma expression in adults. Br. J. Haematol.68(4) , 455–458 (1988).
  • Oner C , DimovskiAJ, AltayC et al. Sequence variations in the 5´ hypersensitive site-2 of the locus control region of beta S chromosomes are associated with different levels of fetal globin in hemoglobin S homozygotes. Blood 79(3) , 813–819 (1992).
  • Merghoub T , PerichonB, Maier-RedelspergerM et al. Dissection of the association status of two polymorphisms in the beta-globin gene cluster with variations in F-cell number in non-anemic individuals. Am. J. Hematol. 56(4) , 239–243 (1997).
  • Dover GJ , SmithKD, ChangYC et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80(3) , 816–824 (1992).
  • Craig JE , RochetteJ, FisherCA et al. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat. Genet. 12(1) , 58–64 (1996).
  • Game L , CloseJ, StephensP et al. An integrated map of human 6q22.3–q24 including a 3-Mb high-resolution BAC/PAC contig encompassing a QTL for fetal hemoglobin. Genomics 64(3) , 264–276 (2000).
  • Ma Q , WyszynskiDF, FarrellJJ et al. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J. 7(6) , 386–394 (2007).
  • Bailey L , KuroyanagiY, Franco-PenteadoCF et al. Expression of the gamma-globin gene is sustained by the cAMP-dependent pathway in beta-thalassaemia. Br. J. Haematol. 138(3) , 382–395 (2007).
  • Papachatzopoulou A , KourakliA, MakropoulouP et al. Genotypic heterogeneity and correlation to intergenic haplotype within high HbF beta-thalassemia intermedia. Eur. J. Haematol. 76(4) , 322–330 (2006).
  • Papachatzopoulou A , KaimakisP, PourfarzadF et al. Increased gamma-globin gene expression in beta-thalassemia intermedia patients correlates with a mutation in 3´HS1. Am. J. Hematol. 82(11) , 1005–1009 (2007).
  • Giannopoulou E , BartsakouliaM, TafraliC et al. A single nucleotide polymorphism in the HBBP1 gene in the human β-globin locus is associated with a mild β-thalassemia disease phenotype. Hemoglobin 36(5) , 433–445 (2012).
  • Borg J , PapadopoulosP, GeorgitsiM et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat. Genet. 42(9) , 801–805 (2010).
  • Borg J , PhylactidesM, BartsakouliaM et al. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. Pharmacogenomics13(13) , 1487–1500 (2012).
  • de Hoon MJ , ImotoS, NolanJ, MiyanoS. Open source clustering software. Bioinformatics20(9) , 1453–1454 (2004).
  • Saldanha AJ . Java Treeview – extensible visualization of microarray data. Bioinformatics20(17) , 3246–3248 (2004).
  • Wyszynski DF , BaldwinCT, ClevesMA et al. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell. Mol. Biol. (Noisy-le-grand) 50(1) , 23–33 (2004).
  • Creary LE , UlugP, MenzelS et al. Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS ONE 4(1) , e4218 (2009).
  • Xu Z , TaylorJA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res.37(Web Server issue) , W600–W605 (2009).
  • Barrett JC , FryB, MallerJ, DalyMJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2) , 263–265 (2005).
  • Papachatzopoulou A , KourakliA, StavrouEF et al. Region-specific genetic heterogeneity of HBB mutation distribution in south-western Greece. Hemoglobin 34(4) , 333–342 (2010).
  • Ye S , DhillonS, KeX, CollinsAR, DayIN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res.29(17) , e88 (2001).
  • Zukic B , RadmilovicM, StojiljkovicM et al. Functional analysis of the role of the TPMT gene promoter VNTR polymorphism in TPMT gene transcription. Pharmacogenomics 11(4) , 547–557 (2010).
  • Kotur N , StankovicB, KasselaK et al. 6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner. Pharmacogenomics 13(3) , 283–295 (2012).
  • Watson J . The significance of the paucity of sickle cells in newborn Negro infants. Am. J. Med. Sci.215(4) , 419–423 (1948).
  • Thein SL , MenzelS, PengX et al. Intergenic variants of HBS1L–MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc. Natl Acad. Sci. USA 104(27) , 11346–11351 (2007).
  • Lettre G , SankaranVG, BezerraMA et al. DNA polymorphisms at the BCL11A, HBS1L–MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl Acad. Sci. USA 105(33) , 11869–11874 (2008).
  • Wahlberg K , JiangJ, RooksH et al. The HBS1L–MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 114(6) , 1254–1262 (2009).
  • Farrell JJ , ShervaRM, ChenZY et al. A 3-bp deletion in the HBS1L–MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood 117(18) , 4935–4945 (2011).
  • Galarneau G , PalmerCD, SankaranVG, OrkinSH, HirschhornJN, LettreG. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat. Genet.42(12) , 1049–1051 (2010).
  • Georgitsi M , ZukicB, PavlovicS, PatrinosGP. Transcriptional regulation and pharmacogenomics. Pharmacogenomics12(5) , 655–673 (2011).
  • Beutler E , GelbartT, DeminaA. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl Acad. Sci. USA95(14) , 8170–8174 (1998).
  • Hoskins JM , GoldbergRM, QuP, IbrahimJG, McLeodHL. UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J. Natl Cancer Inst.99(17) , 1290–1295 (2007).
  • Horie N , AibaH, OguroK, HojoH, TakeishiK. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5´-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct.20(3) , 191–197 (1995).
  • Pullarkat ST , StoehlmacherJ, GhaderiV et al. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 1(1) , 65–70 (2001).
  • Krajinovic M , CosteaI, ChiassonS. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet359(9311) , 1033–1034 (2002).
  • Weatherall DJ . Towards molecular medicine; reminiscences of the haemoglobin field, 1960–2000. Br. J. Haematol.115(4) , 729–738 (2001).
  • Platt OS . Hydroxyurea for the treatment of sickle cell anemia. N. Engl. J. Med.358(13) , 1362–1369 (2008).
  • Matsukawa J , MatsuzawaA, TakedaK, IchijoH. The ASK1–MAP kinase cascades in mammalian stress response. J. Biochem.136(3) , 261–265 (2004).
  • Tobiume K , MatsuzawaA, TakahashiT et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2(3) , 222–228 (2001).
  • Hattori K , NaguroI, RunchelC, IchijoH. The roles of ASK family proteins in stress responses and diseases. Cell Commun. Signal.7 , 9 (2009).
  • Witt O , MonkemeyerS, RönndahlG et al. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101(5) , 2001–2007 (2003).
  • Conti M , JinSL. The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol.63 , 1–38 (1999).
  • Inoue A , KuroyanagiY, TeruiK, MoiP, IkutaT. Negative regulation of gamma-globin gene expression by cyclic AMP-dependent pathway in erythroid cells. Exp. Hematol.32(3) , 244–253 (2004).
  • Kuroyanagi Y , KanekoY, MutaK et al. cAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression. Biochem. Biophys. Res. Commun. 344(3) , 1038–1047 (2006).
  • Keefer JR , SchneidereithTA, MaysA, PurvisSH, DoverGJ, SmithKD. Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. Exp. Hematol.34(9) , 1151–1161 (2006).
  • Ware RE , DespotovicJM, MortierNA et al. Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood 118(18) , 4985–4991 (2011).
  • Flanagan JM , StewardS, HowardTA et al. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia. Br. J. Haematol. 157(2) , 240–248 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.